Pharmaceutical Ingreident CAS 86483-48-9 Ciprofloxacin Hydrochloride
used for urogenital infection caused by sensitive bacteria, including simple, complex urinary tract infection, bacterial prostatitis, neisseria gonorrhoeae urethritis or cervicitis (including those caused by enzyme strains).
Respiratory infections,including acute episodes of bronchial infection caused by sensitive Gram-negative bacilli and pulmonary infections.
Gastrointestinal infection is caused by Shigella, Salmonella, enterotoxin-producing Escherichia coli, aeromonas hydrophila, vibrioparahaemolyticus, etc.It can also treat typhoid bone and joint infection, skin soft tissue infection, sepsis and other systemicinfections.
Certificate of Analysis |
Item |
Specification |
Result |
Assay |
99% |
99.68% |
Appearance |
White powder |
conforms |
Odor |
Characteristic |
conforms |
Taste |
Characteristic |
conforms |
Particle Size |
NLT 100% Through 80 mesh |
conforms |
Loss on Drying |
<2.0% |
0.46% |
Heavy metals |
Total Heavy Metals |
≤10ppm |
conforms |
Arsenic |
≤3ppm |
conforms |
Lead |
≤3ppm |
conforms |
Microbiological Tests |
Total Plate Count |
≤1000cfu/g |
conforms |
Total Yeast & Mold |
≤100cfu/g |
conforms |
E.Coli |
Negative |
Negative |
Salmonella |
Negative |
Negative |
Product Name |
CAS No. |
Product Name |
CAS No. |
Lufenuron |
103055-07-8 |
Toltrazuril |
69004-03-1 |
Nitenpyram |
120738-89-8 |
Praziquantel/Biltricide |
55268-74-1 |
Fenbendazole |
43210-67-9 |
Tetramisole Hcl |
5086-74-8 |
Levamisole |
14769-73-4 |
Ponazuril |
9004-4-2 |
Diclazuril |
101831-37-2 |
Florfenicol |
73231-34-2 |
Ivermectin |
70288-86-7 |
Enrofloxacin Hcl |
112732-17-9 |
Albendazole |
54965-21-8 |
Mebendazole |
31431-39-7 |